135 related articles for article (PubMed ID: 15856009)
1. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
4. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
5. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
6. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
7. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
13. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression levels as independent predictors of survival for osteosarcoma patients.
Osaka E; Suzuki T; Osaka S; Yoshida Y; Sugita H; Asami S; Tabata K; Sugitani M; Nemoto N; Ryu J
J Orthop Res; 2007 Jan; 25(1):116-21. PubMed ID: 17034065
[TBL] [Abstract][Full Text] [Related]
17. [HDMX amplification and high levels of HDMX-S splice variant are correlated with a poor prognosis in soft tissue sarcomas].
Bartel F; Schulz J; Blümke K; Kappler M; Bache M; Schmidt H; Taubert H
Verh Dtsch Ges Pathol; 2004; 88():199-206. PubMed ID: 16892553
[TBL] [Abstract][Full Text] [Related]
18. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
19. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D
Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]